Jennifer Quinones Paniagua
Physician Assistant · Pharr, TXNPI 1831380427
Payments from drug & device makers
Across 349 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$1K
- Novo Nordisk$955
- Bayer$519
- Lilly USA, LLC$493
- Amgen$410
- plus $3K from 34 others
What the payments were for
- Consulting fees$1,20016%
- Food & beverage$6,34184%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 5 | $1,239 |
| AbbVie | 67 | $1,014 |
| Novo Nordisk | 52 | $955 |
| Bayer | 22 | $519 |
| Lilly USA, LLC | 27 | $493 |
| Amgen(2 entities) | 26 | $410 |
| Pfizer | 16 | $368 |
| Radius Health, Inc. | 9 | $213 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $199 |
| AstraZeneca | 11 | $180 |
| GSK | 6 | $122 |
| Exact Sciences | 6 | $119 |
| Lundbeck LLC | 5 | $119 |
| Bausch Health US, LLC | 7 | $118 |
| Esperion Therapeutics, Inc. | 6 | $115 |
| Boehringer Ingelheim | 6 | $113 |
| Abbott | 5 | $112 |
| Merck | 6 | $110 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| IBSA Pharma Inc. | 5 | $95 |
| Amarin Pharma, Inc. | 4 | $75 |
| Currax Pharmaceuticals LLC | 5 | $74 |
| Ascensia Diabetes Care US Inc. | 2 | $60 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| Acella Pharmaceuticals, LLC | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 3 | $55 |
| Antares Pharma, Inc. | 3 | $51 |
| Tolmar, Inc. | 3 | $46 |
| Halozyme Inc | 2 | $45 |
| Millicent US Inc | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Medtronic | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Neurocrine Biosciences, Inc. | 1 | $33 |
| Mannkind Corporation | 2 | $32 |
| Dexcom, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
How this compares
$7,541 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 44 | $49,512 |
| OzempicSemaglutide | 23 | $21,745 |
| Rosuvastatin Calcium | 126 | $1,552 |
| Cefdinir | 60 | $1,068 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 27 | $922 |
| Montelukast Sodium | 63 | $900 |
| Esomeprazole Magnesium | 21 | $691 |
| Pravastatin Sodium | 38 | $582 |
| Amlodipine Besylate | 61 | $570 |
| Gabapentin | 30 | $549 |
| Azelastine Hcl | 27 | $543 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $526 |
| Levothyroxine Sodium | 58 | $453 |
| Pantoprazole Sodium | 51 | $452 |
| Metoprolol Succinate | 37 | $408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $493 | $49,51244 claims |
| Novo NordiskOzempic | $955 | $21,74523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Pharr
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.